ArticleJournal of arthropod-borne diseases2025
The Association between Parasitemia and Liver Enzyme Alterations in Malaria Patients: ABO Blood Group as A Non-Contributory Factor.
Article in Journal of arthropod-borne diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Malaria, a life-threatening parasitic disease, exhibits diverse clinical manifestations influenced by parasite species, host immunity, and treatment access. Emerging evidence suggests that individual biological factors, such as ABO blood group and liver enzyme status, may also affect disease severity. This study investigates the relationship between blood type, liver enzyme levels, and malaria severity in affected patients. Methods: A case-control study was conducted on malaria patients at the National Malaria Laboratory, Tehran University of Medical Sciences, from May 2022 to October 2024. Blood samples were analyzed for ABO blood grouping and liver enzymes: alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP). Malaria severity was classified according to WHO criteria. Statistical analyses, including chi-square tests and logistic regression, evaluated associations between blood group, liver enzyme levels and disease severity. Results: A total of 100 participants were included: 50 malaria-positive patients and 50 healthy controls, with a mean age of 38.10±16.40 years. Malaria patients showed significantly higher AST, ALT and ALP levels compared to controls (p= 0.001). No significant association was found between ABO blood group and liver enzyme levels in either group (p> 0.05). Liver enzyme levels correlated significantly with parasitemia (p< 0.001), with higher parasite loads linked to greater hepatic dysfunction. Conclusion: This study highlights the significant impact of parasitemia levels on liver function in malaria patients, while the ABO blood group appeared unrelated to liver enzyme alterations. Liver enzyme profiles may serve as valuable biomarkers for assessing malaria severity and guiding clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.